Ibex Investors LLC Biond Vax Pharmaceuticals Ltd. Transaction History

Ibex Investors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$2.5 - $40.97 $806,032 - $13.2 Million	-322,413 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$23.7 - $51.1 $143,669 - $309,768	-6,062 Reduced 1.85%	322,413 $12.6 Million
Q2 2020 Aug 12, 2020	SELL	$7.2 - $24.87 $207,108 - $715,385	-28,765 Reduced 8.05%	328,475 $7.47 Million
Q1 2020 May 14, 2020	SELL	$5.36 - $11.65 $9,433 - $20,504	-1,760 Reduced 0.49%	357,240 $2.75 Million
Q4 2019 Feb 05, 2020	SELL	$5.38 - $9.29 $1.93 Million - $3.34 Million	-359,000 Reduced 50.0%	359,000 $3.34 Million
Q4 2019 Feb 05, 2020	BUY	$5.38 - $9.29 $1.93 Million - $3.34 Million	359,000 Added 100.0%	718,000 $6.67 Million
Q4 2017 Feb 14, 2018	BUY	$4.73 - $7.78 $1.7 Million - $2.79 Million	359,000	359,000 $1.92 Million

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.